Like other organisms, bacteria have developed ingenious mechanisms for defending themselves against such invaders. The CRISPR-Cas systems are one such mechanism. The bacterial cells can use CRISPR-Cas ...
Cancer continues to be a formidable challenge globally, with traditional drug discovery methods focusing on cytotoxic agents and targeted therapies altering the landscape of cancer prognosis and ...
CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in ... Knockout of toy using CRISPR/Cas9 technology leads to small-headed honeybees without compound eyes, while ...
Nobel Prize winner and UC Berkeley professor Jennifer Doudna presented developments on her gene research at a UC Santa Barbara Arts & Lectures event on Oct. 22. Her most recent research on DNA ...
While other studies have used the technology to knock out or decrease ... around us but could also provide a new way to control CRISPR-Cas ... Win-Win in Muscle Research: Faster Results and ...
BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology BRAIN can receive up to EUR 92.3 million R&D and commercial milestone fees ...
giving the technology the best chance for success whilst allowing BRAIN Biotech to focus on its core business. BRAIN Biotech will continue to realize additional commercialization options for our ...